CNBC Top Stories

Meta has been de-emphasizing news across Facebook's feed, upending many publishers that had come to rely on referral traffic.

United has 79 Boeing 737 Max 9 aircraft, more than any other carrier.

A lawyer for Donald Trump wants to have him testify Wednesday at the trial for the suit by E. Jean Carroll, a day after the New Hampshire Republican primary.

A review into market trading from two former high-ranking officials criticizes their actions but does not accuse either of doing anything illegal.

The partnership with Carvel is a boon for Oatly, which has seen its share price crumble since its 2021 initial public offering.

Melius Research touts Nvidia's software push and draws a link between Jim Cramer's two "own it, don't trade it" stocks.

Fulton County District Attorney Fani Willis appointed Nathan Wade to oversee the criminal election case against former President Donald Trump.

The broad S&P 500 index has continued to climb to new highs in recent days. Here's what to know about investing in funds that track the index.

Bitcoin was up 155% in 2023 in anticipation of ETF approval. Now that the funds are here, here's what you can expect.

Ukrainian drones struck a major fuel processing and export facility near St. Petersburg, sources in Kyiv told the BBC and The Wall Street Journal.

Bad news for the tech behemoth could be good news for Palo Alto Networks' stock.

Elevated expectations for AI chip growth has led one analyst to admit he has know idea how AMD should be valued.

Spirit shares are down about 50% since a U.S. District Court judge blocked the merger.

Wall Street's biggest banks posted quarterly earnings. Management weighed the impact of the Fed's expected rate cuts on their businesses.

The final stretch of disinflation before hitting the Federal Reserve's 2% target may not be so easy, some economists believe.

Apple's Vision Pro quickly sold out after preorders opened Friday, but early signs could mean demand is waning, a top Apple analyst wrote.

Gilead will discuss the results with regulators and identify whether certain lung cancer patients may still benefit from the drug, known as Trodelvy.

In the last three years, the population of the super wealthy has skyrocketed in the U.S. and around the world.

Chinese companies are releasing new models in record times, and many are producing EVs efficiently and profitably.

Donald Trump's proposed 10% tariff increase on all U.S. imports "shakes up every asset class," according to Rabobank's Michael Every.